Oxford Metrics
OMG · AIM · Technology · mcap £39m · 35.6p 4 open situations →
- EV
- £26.4m
- EV / EBIT
- –
- Net cash
- £13.7m
- FCF yield
- 0.3%
- Revenue
- £45.4m
- Cash returned
- 24.4%
- Share price 1y
- −18%
- Insiders 12m
- bought £417k
- Next report
- in December ●
Oxford Metrics makes Vicon motion capture systems, used in film, games, virtual reality, life sciences and engineering. It is also building a smart manufacturing business, using machine vision and measurement tools for automated quality control.
Open · 4
CEO succession and reset
Follows from Profit warning – profit warningPart of Cost optimisation programme – Expanded; ahead of 2027 plan
CEO Imogen O'Connor stepped down on 7 September 2026 for health reasons; Chair Gary Bullard is interim CEO. On 9 October 2026 the start date for Stefan Lampa was set at 1 December 2026, as Group and Vicon CEO, combining the two roles. Bullard then returns to Non-Executive Chair.
- Incoming CEO
- Stefan Lampa, Group and Vicon Chief Executive 9 Oct 2026 ↗
- Outgoing CEO
- Imogen O'Connor, stepping down with immediate effect for health reasons after 25+ years
- Interim
- Gary Bullard until Lampa starts, then back to Non-Executive Chair 9 Oct 2026 ↗
- Start date
- 1 December 2026 9 Oct 2026 ↗
- Conditions
- Nominated adviser due diligence and Lampa obtaining UK right to work
- Transition
- O'Connor supports key projects through end-2026, then ad hoc consulting
Next: Stefan Lampa joins as Group and Vicon CEO · 1 Dec 2026
- 9 Oct 2026 Start date fixed; Bullard interim until then
- 7 Sep 2026 Interim CEO in place; new CEO due December
2 directors buying
Follows from Profit warning – profit warning
- 9 Oct 2026 A director £58k
- 9 Oct 2026 A director £56k
- 9 Oct 2026 Ms Zoe Fox £21k
Cost optimisation programme
Follows from Profit warning – profit warningIncludes CEO succession and reset – Start date fixed; Bullard interim until then
The cost programme began in June 2026 with £0.8m of annualised savings achieved. On 9 October 2026 it was extended to total net annualised savings of £1.5-2.0m, with c.£1.5m benefiting FY27 after reinvestment. Actions include IVMS integration, removal of lower-margin products and headcount cuts in July and August.
- Total savings
- £1.5-2.0m net annualised, including £0.6m already communicated 9 Oct 2026 ↗
- FY27 benefit
- c.£1.5m after planned reinvestment 9 Oct 2026 ↗
- Actions
- IVMS integration, lower-margin products removed, headcount reductions in July and August 9 Oct 2026 ↗
- Further steps
- Broader product and operating cost review; combine development after move:ai and Captive Devices 9 Oct 2026 ↗
Next: FY27 delivery of c.£1.5m net savings
- 9 Oct 2026 Expanded; ahead of 2027 plan
- 17 Jun 2026 £0.8m annualised savings achieved; more identified
Profit warning
On 17 June 2026 FY26 revenue guidance of c.£56m for the 15 months was confirmed. On 9 October 2026 the Board cut it to £47-51m with an Adjusted EBIT loss of £0.5-3.9m, against market expectations of £56.2m and a £3.0m profit. FY27 EBIT is guided at or above £3.5m on lower revenue.
- FY26 revenue
- £47.0-51.0m versus market expectations of £56.2m 9 Oct 2026 ↗
- FY26 Adj. EBIT
- loss of £0.5-3.9m versus expected £3.0m profit 9 Oct 2026 ↗
- FY27 Adj. EBIT
- at or above market expectations of £3.5m 9 Oct 2026 ↗
- FY27 revenue
- below market expectations of £52.5m 9 Oct 2026 ↗
- Causes
- Weaker Vicon end markets, research funding pressure, delayed IVMS projects 9 Oct 2026 ↗
- Interim results
- 12 months to 30 September 2026, due December 2026 9 Oct 2026 ↗
Next: Interim results for 12 months to 30 September 2026
- 9 Oct 2026 profit warning · -6% on the day
Closed · 7
Company filings. Not investment advice.